GPP
Great Point Partners’s Sarepta Therapeutics SRPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-80,000
| Closed | -$7.71M | – | 42 |
|
|
2023
Q4 | $7.71M | Sell |
80,000
-85,200
| -52% | -$8.22M | 1.31% | 26 |
|
|
2023
Q3 | $20M | Buy |
165,200
+41,600
| +34% | +$5.04M | 3.65% | 9 |
|
|
2023
Q2 | $14.2M | Buy |
+123,600
| New | +$14.2M | 2.77% | 16 |
|
|
2023
Q1 | – | Sell |
-73,000
| Closed | -$9.46M | – | 49 |
|
|
2022
Q4 | $9.46M | Buy |
+73,000
| New | +$9.46M | 1.85% | 22 |
|
|
2022
Q3 | – | Sell |
-193,900
| Closed | -$14.5M | – | 47 |
|
|
2022
Q2 | $14.5M | Buy |
+193,900
| New | +$14.5M | 3.49% | 11 |
|
|
2022
Q1 | – | Sell |
-145,405
| Closed | -$13.1M | – | 39 |
|
|
2021
Q4 | $13.1M | Buy |
+145,405
| New | +$13.1M | 2.91% | 14 |
|
|
2017
Q4 | – | Sell |
-250,000
| Closed | -$11.3M | – | 42 |
|
|
2017
Q3 | $11.3M | Buy |
+250,000
| New | +$11.3M | 2.21% | 15 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 42 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 40 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 33 |
|